Skip to main content
Top

Hereditary Cancer in Clinical Practice

Issue 1/2015

Content (19 Articles)

Open Access Research

Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention

Claire E Wright, Michelle Harvie, Anthony Howell, D Gareth Evans, Nick Hulbert-Williams, Louise S Donnelly

Open Access Case report

Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer

Ana Rafaela de Souza Timoteo, Betina Menezes Albuquerque, Patricia Pascoto Pascoto Moura, Carlos Cesar de Oliveira Ramos, Lucymara Fassarela Agnez-Lima, Tom Walsh, Mary-Claire King, Tirzah Braz Petta Lajus

Open Access Research

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

Tadeusz Dębniak, Tomasz Gromowski, Rodney J Scott, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Grzegorz Kurzawski, Dagmara Dymerska, Bohdan Górski, Katarzyna Paszkowska-Szczur, Cezary Cybulski, Pablo Serrano-Fernandez, Jan Lubiński

Open Access Letter to the Editor

PARP inhibitors

Maheen Anwar, Hafiz Muhammad Aslam, Shahzad Anwar

Open Access Case report

High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report

Maria Fernanda Noriega-Iriondo, Gerardo Colon-Otero, Benjamin R Kipp, John A Copland, Matthew J Ferber, Laura A Marlow, Maegan E Roberts, Matthew W Robertson, Tri A Dinh, Steven Attia, Xochiquetzal J Geiger, Douglas L Riegert-Johnson

Open Access Research

High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients

Dagnija Kalniete, Miki Nakazawa-Miklaševiča, Ilze Štrumfa, Arnis Āboliņš, Arvīds Irmejs, Jānis Gardovskis, Edvīns Miklaševičs

Open Access Research

The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population

Marta Kaczmarek-Ryś, Katarzyna Ziemnicka, Szymon T Hryhorowicz, Katarzyna Górczak, Justyna Hoppe-Gołębiewska, Marzena Skrzypczak-Zielińska, Michalina Tomys, Monika Gołąb, Malgorzata Szkudlarek, Bartłomiej Budny, Idzi Siatkowski, Paweł Gut, Marek Ruchała, Ryszard Słomski, Andrzej Pławski

Open Access Reviewer acknowledgement

Thank you to all our manuscript reviewers in 2014

Jan Lubinski, Rodney J Scott, Rolf Sijmons, Katie Bayliss

Open Access Research

Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers

Holly Etchegary, Elizabeth Dicks, Kathy Watkins, Sabrina Alani, Lesa Dawson

Open Access Research

Interest in genomic SNP testing for prostate cancer risk: a pilot survey

Michael J Hall, Karen J Ruth, David YT Chen, Laura M Gross, Veda N Giri

Open Access Research

Patient experiences living with pancreatic cancer risk

Meghan Underhill, Donna Berry, Emily Dalton, Jaclyn Schienda, Sapna Syngal

Open Access Research

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

Cecilie Heramb, Per Olaf Ekstrøm, Kukatharmini Tharmaratnam, Eivind Hovig, Pål Møller, Lovise Mæhle

Open Access Research

Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden

Camilla Wendt, Annika Lindblom, Brita Arver, Anna von Wachenfeldt, Sara Margolin

Open Access Review

The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers

Helen Cavanagh, Katherine M.A. Rogers

Open Access Review

Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing

Alexandra Tsigginou, Fotios Vlachopoulos, Iordanis Arzimanoglou, Flora Zagouri, Constantine Dimitrakakis

Open Access Research

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes

Michele Simbolo, Andrea Mafficini, Marco Agostini, Corrado Pedrazzani, Chiara Bedin, Emanuele D. Urso, Donato Nitti, Giona Turri, Maria Scardoni, Matteo Fassan, Aldo Scarpa

Open Access Letter to the Editor

The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine

Ielizaveta Gorodetska, Svitlana Serga, Natalia Levkovich, Tetiana Lahuta, Ludmila Ostapchenko, Serhyi Demydov, Nikolay Anikusko, Valeriy Cheshuk, Ivan Smolanka, Svitlana Sklyar, Serhyi Polenkov, Oleksander Boichenko, Iryna Kozeretska

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine